Olokizumab (CDP 6038) is a humanized monoclonal antibody designed to specifically target interleukin-6 (IL-6), a cytokine implicated in the inflammatory response associated with rheumatoid arthritis (RA). This antibody is utilized primarily in the study of inflammatory mechanisms and potential therapeutic interventions for RA. Its specificity for IL-6 makes it a valuable tool in the elucidation of cytokine-driven pathways in disease pathology and in the assessment of novel anti-inflammatory strategies.
Olokizumab (CDP 6038) is a humanized monoclonal antibody designed to specifically target interleukin-6 (IL-6), a cytokine implicated in the inflammatory response associated with rheumatoid arthritis (RA). This antibody is utilized primarily in the study of inflammatory mechanisms and potential therapeutic interventions for RA. Its specificity for IL-6 makes it a valuable tool in the elucidation of cytokine-driven pathways in disease pathology and in the assessment of novel anti-inflammatory strategies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: